AD
Tesamorelin (usan)(CAS: 218949-48-5)
CAS Number
Related Products
Angiotensin amide acetate
CAS Number: 20071-00-5
Atosiban
CAS Number: 90779-69-4
Liraglutide
CAS Number: 204656-20-2
(2S)-N-[(2R)-1-Amino-1-oxo-2-p
CAS Number: 124904-93-4
Alarelin Acetate
CAS Number: 79561-22-1
Other Suppliers for Tesamorelin (usan)
Basic Information
Molecular Formula
C221H366N72O67S
Molecular Weight
5135.78 g/mol
Chemical Identifiers
SMILES
S(C)CC[C@@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@@H](C)C(N[C@H](C(N[C@@H](C)C(N[C@H](C(N[C@H](C(N)=O)CC(C)C)=O)CCCNC(=N)N)=O)=O)CCCNC(=N)N)=O)=O)=O)CCCNC(=N)N)=O)CCC(=O)O)=O)CCC(N)=O)=O)=O)=O)CCC(=O)O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CC(=O)O)NC([C@H](CCC(N)=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CCCCN)NC([C@H](CCCNC(=N)N)NC([C@H](C)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CCC(N)=O)NC(CNC([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@H](CCCCN)NC([C@H](CCCNC(=N)N)NC([C@H](CC1C=CC(=CC=1)O)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@H]([C@@H](C)O)NC([C@H](CC1C=CC=CC=1)NC([C@H]([C@@H](C)CC)NC([C@H](C)NC([C@H](CC(=O)O)NC([C@H](C)NC([C@H](CC1C=CC(=CC=1)O)NC(C/C=C/CC)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
InChIKey
QBEPNUQJQWDYKU-BMGKTWPMSA-N
Database References
MDL Number
MFCD06199102
FAQ
Tesamorelin (CAS: 218949-48-5) is a cyclic pentapeptide with a molecular weight of approximately 850 Da. It has a crystalline form and is soluble in water but poorly soluble in organic solvents. Tesamorelin is relatively stable under acidic conditions but can be hydrolyzed under basic conditions. It is typically stored in a refrigerator at 2-8°C to maintain its stability.
Tesamorelin (CAS: 218949-48-5) is synthesized using solid-phase peptide synthesis (SPPS) techniques. The synthesis involves coupling protected amino acids to a solid support, followed by deprotection and coupling of the next amino acid. The final step includes cyclization and purification using HPLC. Commonly used reagents include Boc-protected amino acids and Fmoc chemistry. The overall yield is around 50-70%, depending on the scale of synthesis.
Tesamorelin (CAS: 218949-48-5) is primarily used in the pharmaceutical industry for the treatment of growth hormone deficiency in adults. It is also of interest in research for its role in modulating somatotropin release, making it relevant for studies in endocrinology and cell biology. Additionally, due to its peptide nature, it may have applications in drug delivery systems and therapeutic peptides.
When handling Tesamorelin (CAS: 218949-48-5), it is important to wear appropriate personal protective equipment (PPE) including gloves and lab coat. Work must be conducted in a well-ventilated area, such as a fume hood, to minimize inhalation risk. Spills should be cleaned up using absorbent materials and properly disposed of according to local regulations. Always consult the Safety Data Sheet (SDS) for detailed handling and disposal instructions. Storage should be in a cool, dry place, away from direct sunlight and sources of heat.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Manager Zhang
lulu@thinheal.com
Mobile
13867485072
Telephone
+86-571-86758863
Visit Website
https://www.thinheal.comAddress
No chemical compound information provided to translate. Please provide the chemical compound information or relevant text for translation.